Health funders would likely have a better return on investment and a stronger position in the global funding crisis if Africans had greater decision-making influence and voting power in global health institutions.

This is an assertion in an article published on 15 September 2025 in the prestigious BMJ Global Health journal.

First EU HTAs with IQWiG involvement launched. The Institute is involved in four oncology drug assessments as an assessor or co-assessor.

A research team led by scientists from the Helmholtz Institute for RNA-based Infection Research (HIRI) has introduced a new way to fine-tune genetic material. Their study, published in Nature Biotechnology, describes an innovative technique in which chemical tags are attached directly to DNA, opening the door to new approaches in medicine, agriculture, and biotechnology.

About The Study: In this decision analytical modeling study of COVID-19 burden in the U.S. in 2024 to 2025, ensemble projections suggested that although vaccinating high-risk groups had substantial benefits in reducing disease burden, maintaining the vaccine recommendation for all individuals had the potential to save thousands more lives. Despite divergence of projections from observed disease trends in 2024 to 2025—possibly driven by variant emergence patterns and immune escape—averted COVID-19 burden due to vaccination was robust across immune escape scenarios, emphasizing the substantial benefit of broader vaccine availability for all individuals.

Twenty-seven species of bacteria and fungi among the hundreds that live in people’s mouths have been collectively tied to a 3.5 times greater risk of developing pancreatic cancer, a study led by NYU Langone Health and its Perlmutter Cancer Center shows.